Literature DB >> 26354764

Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration.

Kristin J Meyers1, Zhe Liu1, Amy E Millen2, Sudha K Iyengar3, Barbara A Blodi1, Elizabeth Johnson4, D Max Snodderly5, Michael L Klein6, Karen M Gehrs7, Lesley Tinker8, Gloria E Sarto9, Jennifer Robinson10, Robert B Wallace10, Julie A Mares11.   

Abstract

PURPOSE: Unhealthy lifestyles have been associated with increased odds for age-related macular degeneration (AMD). Whether this association is modified by genetic risk for AMD is unknown and was investigated.
DESIGN: Interactions between healthy lifestyles AMD risk genotypes were studied in relation to the prevalence of AMD, assessed 6 years later. PARTICIPANTS: Women 50 to 79 years of age in the Carotenoids in Age-Related Eye Disease Study with exposure and AMD data (n=1663).
METHODS: Healthy lifestyle scores (0-6 points) were assigned based on Healthy Eating Index scores, physical activity (metabolic equivalent of task hours/week), and smoking pack years assessed in 1994 and 1998. Genetic risk was based on Y402H in complement factor H (CFH) and A69S in age-related maculopathy susceptibility locus 2 (ARMS2). Additive and multiplicative interactions in odds ratios were assessed using the synergy index and a multiplicative interaction term, respectively. MAIN OUTCOME MEASURES: AMD presence and severity were assessed from grading of stereoscopic fundus photographs taken in 2001-2004. AMD was present in 337 women, 91% of whom had early AMD.
RESULTS: The odds of AMD were 3.3 times greater (95% confidence interval [CI], 1.8-6.1) in women with both low healthy lifestyle score (0-2) and high-risk CFH genotype (CC), relative to those who had low genetic risk (TT) and high healthy lifestyle scores (4-6). There were no significant additive (synergy index [SI], 1.08; 95% CI, 0.70-1.67) or multiplicative (Pinteraction=0.94) interactions in the full sample. However, when limiting the sample to women with stable diets before AMD assessment (n=728) the odds for AMD associated with low healthy lifestyle scores and high-risk CFH genotype were strengthened (odds ratio, 4.6; 95% CI, 1.8-11.6) and the synergy index was significant (SI, 1.34; 95% CI, 1.05-1.70). Adjusting for dietary lutein and zeaxanthin attenuated, and therefore partially explained, the joint association. There were no significant additive or multiplicative interactions for ARMS2 and lifestyle score.
CONCLUSIONS: Having unhealthy lifestyles and 2 CFH risk alleles increased AMD risk (primarily in the early stages), in an or additive or greater (synergistic) manner. However, unhealthy lifestyles increased AMD risk regardless of AMD risk genotype.
Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26354764      PMCID: PMC4714866          DOI: 10.1016/j.ophtha.2015.07.029

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  47 in total

1.  Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study.

Authors:  D Max Snodderly; Julie A Mares; Billy R Wooten; Lisa Oxton; Michael Gruber; Tara Ficek
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

2.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

3.  Healthy lifestyles related to subsequent prevalence of age-related macular degeneration.

Authors:  Julie A Mares; Rick P Voland; Sherie A Sondel; Amy E Millen; Tara Larowe; Suzen M Moeller; Mike L Klein; Barbara A Blodi; Richard J Chappell; Lesley Tinker; Cheryl Ritenbaugh; Karen M Gehrs; Gloria E Sarto; Elizabeth Johnson; D Max Snodderly; Robert B Wallace
Journal:  Arch Ophthalmol       Date:  2010-12-13

4.  The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-11       Impact factor: 5.258

5.  Changes in malondialdehyde and C-reactive protein concentrations after lifestyle modification are related to different metabolic syndrome-associated pathophysiological processes.

Authors:  Fernando Moreto; Hugo T Kano; Gabriel A Torezan; Erick P de Oliveira; Rodrigo M Manda; Okesley Teixeira; Edilaine Michelin; Camila R Correa; Roberto C Burini
Journal:  Diabetes Metab Syndr       Date:  2015-04-25

6.  Quality control and quality assurance in genotypic data for genome-wide association studies.

Authors:  Cathy C Laurie; Kimberly F Doheny; Daniel B Mirel; Elizabeth W Pugh; Laura J Bierut; Tushar Bhangale; Frederick Boehm; Neil E Caporaso; Marilyn C Cornelis; Howard J Edenberg; Stacy B Gabriel; Emily L Harris; Frank B Hu; Kevin B Jacobs; Peter Kraft; Maria Teresa Landi; Thomas Lumley; Teri A Manolio; Caitlin McHugh; Ian Painter; Justin Paschall; John P Rice; Kenneth M Rice; Xiuwen Zheng; Bruce S Weir
Journal:  Genet Epidemiol       Date:  2010-09       Impact factor: 2.135

7.  Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity: how low can you go?

Authors:  Maciej Tomaszewski; Fadi J Charchar; Malgorzata Przybycin; Lynne Crawford; A Michael Wallace; Katarzyna Gosek; Gordon D Lowe; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak; Naveed Sattar; Anna F Dominiczak
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-17       Impact factor: 8.311

8.  Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration.

Authors:  Johanna M Seddon; Robyn Reynolds; Bernard Rosner
Journal:  Mol Vis       Date:  2010-11-17       Impact factor: 2.367

9.  CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.

Authors:  Michael L Klein; Peter J Francis; Bernard Rosner; Robyn Reynolds; Sara C Hamon; Dennis W Schultz; Jurg Ott; Johanna M Seddon
Journal:  Ophthalmology       Date:  2008-06       Impact factor: 12.079

10.  Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.

Authors:  Reecha Sofat; Juan P Casas; Andrew R Webster; Alan C Bird; Samantha S Mann; John R W Yates; Anthony T Moore; Tiina Sepp; Valentina Cipriani; Catey Bunce; Jane C Khan; Humma Shahid; Anand Swaroop; Gonçalo Abecasis; Kari E H Branham; Sepideh Zareparsi; Arthur A Bergen; Caroline C W Klaver; Dominique C Baas; Kang Zhang; Yuhong Chen; Daniel Gibbs; Bernhard H F Weber; Claudia N Keilhauer; Lars G Fritsche; Andrew Lotery; Angela J Cree; Helen L Griffiths; Shomi S Bhattacharya; Li L Chen; Sharon A Jenkins; Tunde Peto; Mark Lathrop; Thierry Leveillard; Michael B Gorin; Daniel E Weeks; Maria Carolina Ortube; Robert E Ferrell; Johanna Jakobsdottir; Yvette P Conley; Mati Rahu; Johan H Seland; Gisele Soubrane; Fotis Topouzis; Jesus Vioque; Laura Tomazzoli; Ian Young; John Whittaker; Usha Chakravarthy; Paulus T V M de Jong; Liam Smeeth; Astrid Fletcher; Aroon D Hingorani
Journal:  Int J Epidemiol       Date:  2012-01-13       Impact factor: 7.196

View more
  19 in total

Review 1.  Lutein and Zeaxanthin Isomers in Eye Health and Disease.

Authors:  Julie Mares
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

Review 2.  From compliment to insult: genetics of the complement system in physiology and disease in the human retina.

Authors:  Robert F Mullins; Alasdair N Warwick; Elliott H Sohn; Andrew J Lotery
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

3.  Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration.

Authors:  Karim Sleiman; Malini Veerappan; Katrina P Winter; Michelle N McCall; Glenn Yiu; Sina Farsiu; Emily Y Chew; Traci Clemons; Cynthia A Toth
Journal:  Ophthalmology       Date:  2017-08-26       Impact factor: 12.079

Review 4.  Nutritional, Alternative, and Complementary Therapies for Age-related Macular Degeneration.

Authors:  Tracy Lister
Journal:  Integr Med (Encinitas)       Date:  2019-12

Review 5.  The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration.

Authors:  Aruna Gorusupudi; Kelly Nelson; Paul S Bernstein
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

6.  Oxidative stress, innate immunity, and age-related macular degeneration.

Authors:  Peter X Shaw; Travis Stiles; Christopher Douglas; Daisy Ho; Wei Fan; Hongjun Du; Xu Xiao
Journal:  AIMS Mol Sci       Date:  2016-05-11

Review 7.  Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review.

Authors:  Ângela Carneiro; José Paulo Andrade
Journal:  Oxid Med Cell Longev       Date:  2017-01-05       Impact factor: 6.543

8.  Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.

Authors:  Liubov Robman; Robyn Guymer; Robyn Woods; Stephanie Ward; Rory Wolfe; James Phung; Lauren Hodgson; Galina Makeyeva; Khin Zaw Aung; Tom Gilbert; Jessica Lockery; Y-Anh Le-Pham; Suzanne Orchard; Elsdon Storey; Walter Abhayaratna; Daniel Reid; Michael E Ernst; Mark Nelson; Christopher Reid; John McNeil
Journal:  Contemp Clin Trials Commun       Date:  2017-03-27

9.  Combined influence of poor health behaviours on the prevalence and 15-year incidence of age-related macular degeneration.

Authors:  Bamini Gopinath; Gerald Liew; Victoria M Flood; Nichole Joachim; George Burlutsky; Paul Mitchell
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

Review 10.  Lutein and Zeaxanthin-Food Sources, Bioavailability  and Dietary Variety in Age-Related Macular  Degeneration Protection.

Authors:  Bronwyn Eisenhauer; Sharon Natoli; Gerald Liew; Victoria M Flood
Journal:  Nutrients       Date:  2017-02-09       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.